Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review-Reference-Cited by-同舟云学术

Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review

Published:2019-01 Issue: Volume:133 Page:163-170
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Belgioia Liliana^ORCID,Desideri Isacco,Errico Angelo,Franzese Ciro,Daidone Antonino,Marino Lorenza,Fiore Michele,Borghetti Paolo^ORCID,Greto Daniela,Fiorentino Alba

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference84 articles.

1. A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer;Albiges;Eur. Urol.,2015

2. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival;Babu;J. Neurosurg.,2016

3. Comprehensive Geriatric Oncology;Balducci,2004

4. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N. Engl. J. Med.,2006

5. Toxicity of definitive and post-operative radiation following ipilimumab in non-small cell lung cancer;Boyer;Lung Cancer,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNA CCAT1 acts as an oncogene to promote radiation resistance in lung adenocarcinoma: an epigenomics-based investigation;Functional & Integrative Genomics;2024-03-07

2. Targeting programmed cell death protein 1 (PD-1) for treatment of non-small-cell lung carcinoma (NSCLC); the recent advances;Pathology - Research and Practice;2023-06

3. Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasis;Journal of Neurosurgery: Spine;2023-05-01

4. Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives;Current Cancer Drug Targets;2023-04

5. The Interaction between Radiotherapy and Immunotherapy in the Treatment of Ma-lignant Tumors;Advances in Clinical Medicine;2023